Financial statements Bowil Biotech

Balance sheet of Bowil Biotech

Company age:
Age:
19 y. 1 m. 13 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BOWIL BIOTECH

Year
2019
2020
2021
2022
2023
Total assets 18 994 504,59 20 158 806,09 19 609 779,86 18 060 997,63 16 133 706,76
A. Fixed assets 14 537 773,68 13 168 270,48 11 938 603,95 11 178 538,70 10 671 089,77
B. Current assets 4 456 730,91 - 7 671 175,91 6 882 458,93 5 462 616,99
C. Share capital contributions (basic funds) - - - 0,00 0,00
D. Own shares (stocks) - - - 0,00 0,00
Total liabilities 18 995 860,32 20 158 806,09 19 609 779,86 18 060 997,63 16 133 706,76
A. Equity 6 637 592,42 7 536 236,46 6 834 182,66 6 076 434,82 5 989 016,44
B. Liabilities and provisions for liabilities 12 358 267,90 12 622 569,63 12 775 597,20 11 984 562,81 10 144 690,32
I. Long-term liabilities 11 265 147,55 9 832 027,51 9 706 866,89 9 551 667,43 0,00
II. Short-term liabilities 1 088 720,58 1 480 646,56 1 212 340,22 1 226 505,29 10 144 690,32
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.